STK11 alterations in the pan-cancer setting: prognostic and therapeutic implications - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/33744718/

Across cancers, STK11 alterations correlated with a poor prognosis regardless of therapy. However, STK11 alterations alone did not associate with inferior immunotherapy outcome in the pan-cancer setting or in NSCLC. Pan-cancer patients with co-altered STK11/KRAS did worse, regardless of treatment ty ...